Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,165.08
(
0.80%
)
US TECH 100
26,538.40
(
1.85%
)
Dow Jones
49,247.66
(
-0.13%
)
Brent Oil
100.66
(
0.00%
)
Bitcoin
77,539.20
(
0.09%
)
News Focus
News Focus
Post# of 822795
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Galzus Research

Send PM Follow Ignore
Followers 1
Posts 430
Boards Moderated 0
Alias Born 12/14/2024

Galzus Research

Re: Arby2000 post# 765745

Saturday, 05/03/2025 7:01:14 PM

Saturday, May 03, 2025 7:01:14 PM

Post# of 822795
It's an ethics issue, despite the fact that the commenter in question didn't take payments from Novocure. His clinic offers Optune. He didn't do research through Novocure, didn't sit on an SAB of Novocure, didn't take an honorarium from activites funded by Novocure.

What conflict? And the fact that the best retorts were "hey this guy is part of a system that offers Optune. Clearly we can't trust his motives!" without addressing the critiques laid out is telling.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent NWBO News
More NWBO News